Survival Analysis of Postoperative Adjuvant Chemotherapy for Stage <scp>IB</scp> Non‐Small Cell Lung Cancer Based on Racial Stratification
There are significant racial differences in the efficacy of adjuvant chemotherapy for stage IB NSCLC, suggesting that treatment decisions need to be optimized in combination with racial background.
Authors
- Xiaobin Qi (ORCID: https://orcid.org/0000-0002-8766-3944)
- Shaowei Xin (ORCID: https://orcid.org/0000-0002-7606-134X)
- Yong Han (ORCID: https://orcid.org/0000-0002-5325-1722)
- Tao Wang (ORCID: https://orcid.org/0000-0001-8839-6158)
- Lei Hou (ORCID: https://orcid.org/0009-0006-4381-3775)
- C. Ye
Institutions
- Heilongjiang Provincial Hospital (CN)
- Tang Du Hospital (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- ANZ Journal of Surgery
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1111/ans.70317
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Wu Jieping Medical Foundation